Dr. Philip Lee is an entrepreneur and technology platform builder specializing in cellular systems. He is the co-founder and Chief Technology Officer for Senti Biosciences, where he oversees technical operations and manufacturing of the company’s gene circuit enabled allogeneic cell therapies. Prior to Senti, Dr. Lee was a co-founder of CellASIC Corp, where he served as the Head of Cell Culture Systems and New Business Initiatives Lead. He received his Ph.D. in Bioengineering from UC Berkeley and UCSF, and Bachelor of Science in Chemical Engineering and Biology from MIT.